Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Psychopharmacology (Berl). 2009 Apr 1;205(1):119. doi: 10.1007/s00213-009-1521-8

Figure 2.

Figure 2

Amisulpride (▲) and 5-HT (■) versus [3H]5-CT competition binding at 5-HT7a receptors. The comparatively low affinity of amisulpride for [3H]5-CT, a 5-HT7a agonist with high intrinsic activity that preferentially binds high affinity sites, in contrast with its higher affinity for [3H]LSD, a very weak partial agonist that labels primarily low affinity antagonist binding sites, suggests that amisulpride is an antagonist at 5-HT7a receptors.